ECS BOTANICS HOLDINGS ORD
ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter
ECS Botanics Holdings (ASX: ECS) has delivered a positive net operating cash flow of $140,000 for the three months to end September, representing an improvement of $1.6 million on the June quarter and $900,000 on the same time last year. The company’s direct-to-consumer (B2C) strategy generated strong results to complement its established business-to-business (B2B) and export […]
ECS Botanics reports 50% increase in cannabis yields with new crop enclosure designs
Australian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has reported a 50% increase in cannabis flower yields following the first harvest from its redesigned protective crop enclosures. The harvest produced 656 kilograms (wet weight) of flower compared to the previous high of 437kg of the same strain, also recording improvements in flower quality […]
ECS Botanics signs medicinal cannabis supply deal with MediCann Health
Victorian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has secured a deal to supply $24 million of pharmaceutical-grade medicinal cannabis dried flower to Perth-based MediCann Health. The agreement will commence in January 2024 with over four tonnes of product to be delivered exclusively to MediCann over five years. It stipulates annual volumes of […]
Ongoing cannabis product demand drives more revenue growth for ECS Botanics
Medicinal cannabis and hemp company ECS Botanics (ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent […]
